Kevin Church, CHIEF SCIENTIFIC OFFICER at Athira Pharma, Inc. (ATHA), sold 2,412 shares at $2.91 ($7K) on 2024-01-05, disclosed to the SEC on 2024-02-16.
Open-market sale of $7k ATHA by CHIEF SCIENTIFIC OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATHA | SELL | 2025-07-02 | $2K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $5K | — | Filing → |
| ATHA | SELL | 2024-09-05 | $1K | — | Filing → |